Paperpal Prime Logo

Revue Neurologique : Impact Factor & More

eISSN: 2213-0004pISSN: 0035-3787

Key Metrics

CiteScore
4
Impact Factor
< 5
SNIP
1.06
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Revue Neurologique

Revue Neurologique Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
Overview
Publisher MASSON EDITEUR
Language French
Frequency Monthly
General Details
LanguageFrench
FrequencyMonthly
Publication Start Year1893
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Revue Neurologique ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Revue Neurologique

Ravulizumab rescue therapy in a refractory AQP4-positive neuromyelitis optica attack with extensive encephalomyelitis.
  • 3 Aug 2026
  • Revue neurologique
French guidelines for the diagnosis and management of neuromyelitis optica spectrum disorder.
  • 21 Jul 2026
  • Revue neurologique
French guidelines for post-polio syndrome and management of effects of aging in people with sequelae of acute anterior poliomyelitis.
  • 21 Jul 2026
  • Revue neurologique
A multi-outcome prognostic score for therapeutic responses in multiple sclerosis.
  • 21 Jul 2026
  • Revue neurologique
Real-world assessment of effectiveness and safety of candesartan in migraine prevention: Results of the French FHU InovPain registry.
  • 15 Jul 2026
  • Revue neurologique
Beyond migraine: A narrative review of photophobia's clinical spectrum.
  • 9 Jul 2026
  • Revue neurologique
Ravulizumab rescue therapy in a refractory AQP4-positive neuromyelitis optica attack with extensive encephalomyelitis.
  • 3 Aug 2026
  • Revue neurologique
French guidelines for the diagnosis and management of neuromyelitis optica spectrum disorder.
  • 21 Jul 2026
  • Revue neurologique
French guidelines for post-polio syndrome and management of effects of aging in people with sequelae of acute anterior poliomyelitis.
  • 21 Jul 2026
  • Revue neurologique
A multi-outcome prognostic score for therapeutic responses in multiple sclerosis.
  • 21 Jul 2026
  • Revue neurologique
Real-world assessment of effectiveness and safety of candesartan in migraine prevention: Results of the French FHU InovPain registry.
  • 15 Jul 2026
  • Revue neurologique
Beyond migraine: A narrative review of photophobia's clinical spectrum.
  • 9 Jul 2026
  • Revue neurologique

FAQs on Revue Neurologique